FY2026 EPS Estimates for MetLife Raised by DOWLING & PARTN

Posted by on Aug 19th, 2026

MetLife, Inc. (NYSE:MET – Free Report) – Equities researchers at DOWLING & PARTN upped their FY2026 earnings per share (EPS) estimates for MetLife in a note issued to investors on Friday, August 14th. DOWLING & PARTN analyst J. Hurwitz now forecasts that the financial services provider will post earnings of $10.10 per share for the year, up from their previous estimate of $9.90. The consensus estimate for MetLife’s current full-year earnings is $9.70 per share.

MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.30 by $0.13. The business had revenue of $13.52 billion during the quarter, compared to analyst estimates of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%.MetLife’s revenue for the quarter was up 10.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.02 earnings per share.

Several other research firms have also issued reports on MET. Weiss Ratings raised shares of MetLife from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, June 15th. Keefe, Bruyette & Woods lifted their price target on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a report on Tuesday, August 11th. Wells Fargo & Company reiterated an “overweight” rating on shares of MetLife in a research report on Wednesday. Barclays increased their price objective on shares of MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Finally, Wall Street Zen downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.07.

Check Out Our Latest Stock Analysis on MET

MetLife Stock Up 0.2%

NYSE MET opened at $96.83 on Wednesday. MetLife has a 52 week low of $67.33 and a 52 week high of $100.93. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $62.31 billion, a P/E ratio of 18.55, a price-to-earnings-growth ratio of 0.75 and a beta of 0.78. The stock’s 50-day moving average price is $92.00 and its 200-day moving average price is $81.86.

MetLife declared that its board has authorized a share repurchase plan on Wednesday, August 5th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to purchase up to 4.8% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its stock is undervalued.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. This represents a $2.37 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, August 4th. MetLife’s dividend payout ratio (DPR) is 45.40%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Kingsview Wealth Management LLC bought a new stake in shares of MetLife during the second quarter valued at approximately $744,000. Beacon Pointe Advisors LLC purchased a new position in shares of MetLife in the second quarter worth $1,547,000. Livforsakringsbolaget Skandia Omsesidigt bought a new position in shares of MetLife during the second quarter worth $487,000. Rakuten Investment Management Inc. purchased a new position in MetLife during the second quarter valued at $7,670,000. Finally, Glenview Trust Co bought a new stake in MetLife in the 2nd quarter valued at $3,363,000. 94.99% of the stock is currently owned by institutional investors.

About MetLife

(Get Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Read More

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.